Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
18.57
-0.92 (-4.72%)
At close: Oct 29, 2025, 4:00 PM EDT
18.55
-0.02 (-0.11%)
After-hours: Oct 29, 2025, 4:05 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $163.57 million as of October 29, 2025. Its market cap has increased by 691.65% in one year.
Market Cap
163.57M
Enterprise Value
42.68M
1-Year Change
691.65%
Ranking
Category
Stock Price
$18.57
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $163.57M, an increase of 2,142.65%. That is a compound annual growth rate of 63.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 170.85M | 177.18% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | 129.17M | 1,226.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 732.82B |
| Johnson & Johnson | 457.36B |
| AbbVie | 402.55B |
| UnitedHealth Group | 329.45B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 219.12B |